2018
DOI: 10.1021/jacs.8b01754
|View full text |Cite
|
Sign up to set email alerts
|

Enantioselective Synthesis of Chiral-at-Cage o-Carboranes via Pd-Catalyzed Asymmetric B–H Substitution

Abstract: Carborane cage chirality is an outstanding issue of great interest as the icosahedral carboranes have wide applications in medicinal and materials chemistry. The synthesis of optically active carborane derivatives, whose chirality is associated with the substitution patterns on the polyhedron, will open new avenues to carborane chemistry. We report herein an efficient method to achieve chiral-at-cage arylation of o-carboranes with high regio- and enantioselectivities by a strategy of palladium-catalyzed asymme… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
22
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 73 publications
(28 citation statements)
references
References 53 publications
0
22
0
Order By: Relevance
“…32,33 As opposed to carbon cage structures, for carboranes manifold achiral, chiral and chiral-at-cage modifications at carbon-as well as at boron-vertices are described in the literature, thus paving the way also for the evaluation and design of target-specific asymmetric drugs. 34,35 While boron-containing drugs like bortezomib, crisaborole and tavaborole are established therapeutics, carborane drugs are still scarce in clinical trials. 30,36,37,38 Within this branch, a limited number of boron-containing HDACis have been investigated.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…32,33 As opposed to carbon cage structures, for carboranes manifold achiral, chiral and chiral-at-cage modifications at carbon-as well as at boron-vertices are described in the literature, thus paving the way also for the evaluation and design of target-specific asymmetric drugs. 34,35 While boron-containing drugs like bortezomib, crisaborole and tavaborole are established therapeutics, carborane drugs are still scarce in clinical trials. 30,36,37,38 Within this branch, a limited number of boron-containing HDACis have been investigated.…”
Section: Introductionmentioning
confidence: 99%
“… 32,33 As opposed to carbon cage structures, for carboranes manifold achiral, chiral and chiral-at-cage modifications at carbon- as well as at boron-vertices are described in the literature, thus paving the way also for the evaluation and design of target-specific asymmetric drugs. 34,35 …”
Section: Introductionmentioning
confidence: 99%
“…However, there are limited reports on the enantioselective synthesis of such chiral compounds, and their utility has not been explored. 28 31 …”
Section: Introductionmentioning
confidence: 99%
“…Inspired by the recent reports on fullerene cage chirality 36 39 and ferrocene planar chirality 40 , the transition-metal-catalyzed enantioselective B–H functionalization should realize the synthesis of optically pure chiral-at-cage o -carborane derivatives, which are important in the fields of asymmetric synthesis, materials science, and medicinal chemistry, where the chirality plays an important role in molecular design. We have very recently reported a proof-of-concept study on enantioselective synthesis of chiral-at-cage o -carborane derivatives via a Pd-catalyzed intramolecular B(5)–H arylation of o -carboranes in the presence of chiral phosphine ligands 41 .
Fig.
…”
Section: Introductionmentioning
confidence: 99%